N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country

If a flu pandemic strikes the United States, a Novartis plant in North Carolina now stands ready to respond with vaccine techniques that offer speed and scalability advantages over traditional vaccine-making methods.
MedCity News